Modern CTMS platforms drive faster, smarter clinical trials with real-time oversight, compliance automation, and integrated site and vendor management.
Quanticate analyze whether having a Dose Expansion Phase in Phase I Oncology Trials is beneficial and provides information about Efficacy, Safety, Toxicity and Pharmacokinetics prior to jumping into a Phase II Study